Skip to content

Latest news

Another milestone reached for AlzeCure's Phase II clinical trial in neuropathic pain with non-opioid ACD440

The first patient has been enrolled in the phase II clinical trial for neuropathic pain treated with the non-opioid ACD440. The Phase II clinical trial is a double-blind, placebo-controlled, randomized cross-over study evaluating the efficacy, safety, and pharmacokinetics of AlzeCure's leading drug candidate in pain, ACD440. Results from the study are expected in mid-2023.

Social media

Press contacts

Claudia Wennberg

Claudia Wennberg

Press contact Marketing and Brand Manager Marketing, Branding and PR +46708244398

Your trusted strategic CRO partner

LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. We offer a well-integrated local presence in the Nordics, UK, and Germany. Reaching from early phase development to post-marketing, we provide expert guidance across every aspect of a project – all from ONE source.

LINK Medical
Gjerdrums vei 19
NO-0484 Oslo
Norway